Efthalia Moustakli

Efthalia Moustakli


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EMEfthalia Moustakli
Efthalia Moustakli
SSSofoklis Stavros
Sofoklis Stavros
ΘΜΘεολόγος M. Μιχαηλίδης
Θεολόγος M. Μιχαηλίδης
Anastasios PotirisAnastasios Potiris
Anastasios Potiris
CCCHRISTODOULAKI CHRYSI
CHRISTODOULAKI CHRYSI
AZAthanasios Zikopoulos
Athanasios Zikopoulos
Concern over COVID-19’s long-term influence on women’s reproductive health is growing, with emerging research suggesting potential links to ovarian dysfunction, menstrual irregularities, fertility challenges, and adverse pregnancy outcomes. Post-viral immune dysregulation is linked to both the development and exacerbation of autoimmune diseases, including multiple sclerosis (MS). Long COVID has been associated with immunological dysfunction, hormonal imbalances, and chronic inflammation, all of which may worsen autoimmune disorders and reproductive health issues. Long COVID is characterized by symptoms persisting for weeks or months beyond the acute infection phase. There are indications that prolonged COVID may contribute to autoimmune disease development through mechanisms such as immune hyperactivation, molecular mimicry, and dysregulated cytokine responses. Although this research field is still emerging, growing evidence suggests that SARS-CoV-2 infection may have lasting effects on women’s health, highlighting the need for further studies into its underlying mechanisms and long-term clinical outcomes. This review compiles recent findings on the long-term impact of COVID-19 on women’s reproductive health and its potential association with autoimmune disorders, particularly MS.